Tags

Type your tag names separated by a space and hit enter

[Bone loss owing to inflammatory bowel disease: prospective study, 50 cases].
Tunis Med. 2009 Feb; 87(2):144-8.TM

Abstract

AIMS

To evaluate the prevalence of osteoporosis during inflammatory bowel disease (IBD) and to determine the risk factors.

METHODS

We conducted a prospective study that includes IBD patients. For all patients, bone mineral density was measured by dual-energy X-rays absorptiometry.

RESULTS

Study has included 50 IBD patients; thirty had Crohn's disease and 20 had ulcerative colitis. The average age of our patients was of 36.4 + 9.9 years. A low osseous mineral density was noted in 21 patients (45%) distributed in 13% of osteoporosis and 32% of osteopenia. Only the age superior to 35 years, the duration of evolution of the disease superior to 10 years and intestinal resection constituted a risk factors of osteoporosis. After adaptation on the age and the intestinal resection the duration of evolution superior to 10 years persisted as risk factor of osteoporosis. The other risk factors: sex, type of IBD, denutrition and corticoids were not incriminated in the low osseous mineral density during IBD.

CONCLUSION

These results confirm the necessity of the systematic search of the osteoporosis during IBD with the aim of proposing an early and effective treatment.

Authors+Show Affiliations

Service de Médecine Interne, Hôpital des Forces de sécuritée Intérieure. 2070 La Marsa.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

English Abstract
Journal Article

Language

fre

PubMed ID

19522449

Citation

Ben Hamida, Kaouther Saadallaoui, et al. "[Bone Loss Owing to Inflammatory Bowel Disease: Prospective Study, 50 Cases]." La Tunisie Medicale, vol. 87, no. 2, 2009, pp. 144-8.
Ben Hamida KS, Serghini M, Ksontini I, et al. [Bone loss owing to inflammatory bowel disease: prospective study, 50 cases]. Tunis Med. 2009;87(2):144-8.
Ben Hamida, K. S., Serghini, M., Ksontini, I., Kedadi, H., Ben Yaghléne, L., Bougassas, W., & Dougui, M. H. (2009). [Bone loss owing to inflammatory bowel disease: prospective study, 50 cases]. La Tunisie Medicale, 87(2), 144-8.
Ben Hamida KS, et al. [Bone Loss Owing to Inflammatory Bowel Disease: Prospective Study, 50 Cases]. Tunis Med. 2009;87(2):144-8. PubMed PMID: 19522449.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Bone loss owing to inflammatory bowel disease: prospective study, 50 cases]. AU - Ben Hamida,Kaouther Saadallaoui, AU - Serghini,Meriem, AU - Ksontini,Iméne, AU - Kedadi,Hanéne, AU - Ben Yaghléne,Lamia, AU - Bougassas,Wassila, AU - Dougui,Mohamed Hedi, PY - 2009/6/16/entrez PY - 2009/6/16/pubmed PY - 2009/8/1/medline SP - 144 EP - 8 JF - La Tunisie medicale JO - Tunis Med VL - 87 IS - 2 N2 - AIMS: To evaluate the prevalence of osteoporosis during inflammatory bowel disease (IBD) and to determine the risk factors. METHODS: We conducted a prospective study that includes IBD patients. For all patients, bone mineral density was measured by dual-energy X-rays absorptiometry. RESULTS: Study has included 50 IBD patients; thirty had Crohn's disease and 20 had ulcerative colitis. The average age of our patients was of 36.4 + 9.9 years. A low osseous mineral density was noted in 21 patients (45%) distributed in 13% of osteoporosis and 32% of osteopenia. Only the age superior to 35 years, the duration of evolution of the disease superior to 10 years and intestinal resection constituted a risk factors of osteoporosis. After adaptation on the age and the intestinal resection the duration of evolution superior to 10 years persisted as risk factor of osteoporosis. The other risk factors: sex, type of IBD, denutrition and corticoids were not incriminated in the low osseous mineral density during IBD. CONCLUSION: These results confirm the necessity of the systematic search of the osteoporosis during IBD with the aim of proposing an early and effective treatment. SN - 0041-4131 UR - https://www.unboundmedicine.com/medline/citation/19522449/[Bone_loss_owing_to_inflammatory_bowel_disease:_prospective_study_50_cases]_ L2 - http://www.latunisiemedicale.com/article-medicale-tunisie.php?article=1040 DB - PRIME DP - Unbound Medicine ER -